Pacs (PACS) Cash & Equivalents (2023 - 2026)

Pacs has disclosed Cash & Equivalents across 4 years of filings, most recently posting $248.0 million for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $248.0 million, down 13.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $248.0 million (down 13.75% YoY), and the FY2025 annual result was $197.0 million, up 24.95% from the prior year.
• Cash & Equivalents came in at $248.0 million for Q1 2026 at Pacs, up from $197.0 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $355.7 million in Q3 2025 to a low of $38.2 million in Q2 2023.
• The 4-year median for Cash & Equivalents is $94.3 million (2023), against an average of $155.3 million.
• Across the five-year window, Cash & Equivalents retreated 28.33% in 2024 and soared 618.25% in 2025, its largest moves.
• Pacs' Cash & Equivalents stood at $73.4 million in 2023, then jumped by 114.77% to $157.7 million in 2024, then advanced by 24.95% to $197.0 million in 2025, then rose by 25.87% to $248.0 million in 2026.
• The last three Cash & Equivalents figures came in at $248.0 million (Q1 2026), $197.0 million (Q4 2025), and $355.7 million (Q3 2025), per Business Quant data.